Anti-Occludin antibody [EPR20992] (Ab216327)
Occludin, OCLN
详细信息
特异性
This antibody is not suitable for ICC in mouse or rat species or for any testing rat intestinal tissues. FURTHER INFORMATION ON SPECIFICITY (Chinese Version) available under the product protocols section. This file includes key technical notes of experience when using this product.
背景信息
Anti-Occludin antibody [EPR20992] (ab216327) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-Fr, IHC-P, IP and WB. Anti-Occludin antibody [EPR20992] (ab216327) was first used in a scientific publication in 2018 and has been cited over 237 times in peer reviewed journals. It's performance in Western blot in human, mouse and rat samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Occludin antibody [EPR20992] (ab216327) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Occludin antibody [EPR20992] (ab216327) has been confirmed by Western Blot testing in Occludin knockout HAP1 cells. Anti-Occludin antibody [EPR20992] (ab216327) has 8 independent reviews from customers. Anti-Occludin antibody [EPR20992] (ab216327) specifically detects Occludin (UniProt ID: Q16625; Molecular weight: 60kDa) and is sold in a convenient trial size to enable initial testing (10 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPR20992 - ab224526. Occludin is a tight junction protein that plays a crucial role in maintaining the integrity of epithelial and endothelial barriers. In oncology, its downregulation is associated with increased tumorigenic and metastatic potential in cancers such as lung carcinoma, making it a potential prognostic biomarker and therapeutic target. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (424)
Gut microbiota-derived tryptophan metabolites improve total parenteral nutrition-associated infections by regulating Group 3 innate lymphoid cells
肠道菌群衍生的色氨酸代谢物通过调节第3组固有淋巴细胞来改善全肠外营养相关感染。
Modular assembled biomimetic nanobubbles for synergistic therapy of ischemic stroke via cascade modulation thrombo-inflammatory network.
模块化组装仿生纳米气泡通过级联调节血栓炎症网络协同治疗缺血性中风
Polystyrene nanoplastics disrupt the intestinal microenvironment by altering bacteria-host interactions through extracellular vesicle-delivered microRNAs.
聚苯乙烯纳米塑料通过细胞外囊泡递送的微RNA改变细菌与宿主的相互作用,从而破坏肠道微环境
PEAK1 maintains tight junctions in intestinal epithelial cells and resists colitis by inhibiting autophagy-mediated ZO-1 degradation.
PEAK1 维持肠道上皮细胞的紧密连接,并通过抑制自噬介导的 ZO-1 降解来抵抗结肠炎
Gut microbiota-derived tryptophan metabolites regulated by Wuji Wan to attenuate colitis through AhR signaling activation
戊己丸调节肠道菌群衍生的色氨酸代谢物,通过激活 AhR 信号减轻结肠炎
Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates.
用于治疗非人灵长类动物新生血管性年龄相关性黄斑变性的肽结合阿柏西普滴眼液
The Gut Microbiota-Xanthurenic Acid-Aromatic Hydrocarbon Receptor Axis Mediates the Anticolitic Effects of Trilobatin.
肠道菌群-黄尿酸-芳香烃受体轴介导三叶苷的抗结肠炎作用
Anti-diabetic effect of dicaffeoylquinic acids is associated with the modulation of gut microbiota and bile acid metabolism.
二咖啡酰奎宁酸的抗糖尿病作用与肠道菌群和胆汁酸代谢的调节有关
Gut microbial dysbiosis exacerbates long-term cognitive impairments by promoting intestinal dysfunction and neuroinflammation following neonatal hypoxia-ischemia
肠道微生物失调会促进新生儿缺氧缺血后的肠道功能障碍和神经炎症,从而加剧长期认知障碍
- 1
- 2
- 3
- 4
- 5
- 6
- 43